Williams M T, Gaylor J L, Morris H P
Cancer Res. 1977 May;37(5):1377-83.
Previously, we reported that the properties or microsomal 4-methyl sterol demethylase isolated from liver and Morris hepatomas 5123C and 7777 are grossly similar. The individual enzymic steps of this multicomponent system have now been studied, and the rate-determining step has been determined and shown to be identical for liver and these hepatomas. The rates of microsomal oxidative attacks of the 4alpha-methyl, 4alpha-hydroxymethyl, and 4-aldehydic groups are similar for microsomes prepared from rat liver and hepatoma 7777. The rates of mixed-function oxidative attack appear to increase in the order;--CH3 less than --CH2OH less than --CHO. Furthermore, the hepatic and hepatoma NAD-dependent decarboxylase, which catalyzes the reaction following the three oxidative attacks is similar in properties and velocity. The fifth step, an NADPH-dependent reduction of the 3 ketosteroid that is produced by decarboxylation, is also similar. For both tissues, the latter two reactions, under in vitro conditions, proceed at rates that exceed the initial oxidative process. Thus, for elimination of both of the 4-methyl groups of lanosterol, the 10 individual reactions catalyzed in this multicomponent system are identical in liver and hepatoma 7777 microsomes, and the rate-determining stop for both liver and hepatoma is the inital oxidative attack on the 4alpha-methyl group of cholesterol procursors. When the rate-determining reaction of both liver and hepatoma 7777 microsomes is assayed at different temperatures, the same activation energies and the same characteristic breaks in the arrhenius plots are observed. Thus, for both liver and hepatoma, both the nature and the site of rate determination in this multienzymic system must be similar. Since the microsomal enzymes of liver nad hepatoma appear to be catalytically similar and rate determination appears to be similar, too, the characteristic lact of response of tumor microsomes to treatments in vivo that alter host liver microsomal demethylation activity suggests that the insensitivity of these tumors to dietary cholesterol should not be ascribed to alterations in the catalytic proteins. Evidence in this report suggests that the postmicrosomal supernatant fraction of both liver and hepatoma contains a cytosolic protein that may participate in the regulation of the rate-determining attack of 4alpha-methyl sterol substrates. Thus, either qualitative or quantitative differences between the postmicrosomal supernatant fractions obtained from liver and heptomas may account for the observed differences in rates of cholesterol biosynthesis.
此前,我们报道从肝脏以及莫里斯肝癌5123C和7777中分离出的微粒体4-甲基甾醇脱甲基酶的性质大致相似。现在已经对这个多组分系统的各个酶促步骤进行了研究,确定了限速步骤,并表明肝脏和这些肝癌的限速步骤是相同的。从大鼠肝脏和肝癌7777制备的微粒体对4α-甲基、4α-羟甲基和4-醛基的微粒体氧化攻击速率相似。混合功能氧化攻击的速率似乎按以下顺序增加:--CH3 < --CH2OH < --CHO。此外,催化三次氧化攻击后反应的肝脏和肝癌NAD依赖性脱羧酶在性质和速度上相似。第五步,即对脱羧产生的3-酮类固醇的NADPH依赖性还原,也相似。对于这两种组织,在体外条件下,后两个反应的进行速率超过初始氧化过程。因此,对于羊毛甾醇的两个4-甲基的消除,这个多组分系统中催化的10个单独反应在肝脏和肝癌7777微粒体中是相同的,并且肝脏和肝癌的限速步骤是对胆固醇前体的4α-甲基的初始氧化攻击。当在不同温度下测定肝脏和肝癌7777微粒体的限速反应时,观察到相同的活化能和相同的阿累尼乌斯图中的特征断点。因此,对于肝脏和肝癌来说,这个多酶系统中限速的性质和部位一定是相似的。由于肝脏和肝癌的微粒体酶在催化上似乎相似,限速也似乎相似,肿瘤微粒体对体内改变宿主肝脏微粒体脱甲基活性的处理缺乏特征性反应,这表明这些肿瘤对膳食胆固醇不敏感不应归因于催化蛋白的改变。本报告中的证据表明,肝脏和肝癌的微粒体后上清液部分含有一种胞质蛋白,它可能参与4α-甲基甾醇底物限速攻击的调节。因此,从肝脏和肝癌获得的微粒体后上清液部分之间的定性或定量差异可能解释了观察到的胆固醇生物合成速率的差异。